Diseases, Conditions, Syndromes

Pirfenidone: Extent of added benefit assessed

Pirfenidone inhibits the development of inflammation and scarring (fibrosis) in pulmonary tissue and has been approved for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) since the beginning of 2011. ...

Alzheimer's disease & dementia

Challenging assumptions on the economic costs of dementia

Increasingly severe cognitive, behavioral, or motor symptoms due to the dysfunction and death of the brain's nerve cells are the hallmarks of the diseases that cause dementia. There is no cure and, therefore, patients with ...

Dentistry

U.S. sees significant shortage in minority dentists

Underrepresented minority dentists represent a smaller percentage of the dental workforce and are unevenly distributed in relation to minority populations in the United States, according to a study by researchers at UC San ...

Diseases, Conditions, Syndromes

What medications are safe in cases of COVID-19?

There is plenty of information floating around the Internet about what medications may or may not be useful in treating the symptoms associated with COVID-19. The extent of the pandemic, coupled with our digital capabilities, ...

page 4 from 36